Brian Crombie Radio Hour - Epi 375 - Bamlanivimab for the Treatment of Covid19 with Dr. Carl Hansen
![Brian Crombie Radio Hour - Epi 375 - Bamlanivimab for the Treatment of Covid19 with Dr. Carl Hansen](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/7ea09d51a62db874962abfa1252978f9.jpg)
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Brian Crombie has a provocative interview with Dr. Carl Hansen, CEO of AbCellera Biologics, a British Columbia-based company that has developed a neutralizing monoclonal antibody treatment, bamlanivimab for the treatment...
show moreAbCellera CEO and co-founder Carl Hansen calls Canada’s reluctance to deploy the company’s COVID-19 treatment “absolutely appalling and inexcusable.”
In the U.S., bamlanivimab has been used to treat hundreds of thousands of COVID patients; Biden White House said monoclonal antibody treatments save one life for every 52 doses administered. Canada has also authorized the treatment. But while the federal government has purchased thousands of doses, provincial governments have balked at making them available to doctors, citing the logistical challenges of administering the treatment and a lack of evidence that it works.
Information
Author | NEWSTALK Sauga 960 AM |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company